Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jellinger

Showing results (241-250 of 364) with videos related to

Pageof 37
Sort By:
Neuropathology and Applied Neurobiology|October 16, 2010
Review: sporadic cerebral amyloid angiopathyJ Attems, K Jellinger, D R Thal, et al.
FEBS Letters|April 24, 1990
A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick diseaseR Weiler, H Lassmann, P Fischer, et al.
Neurology|March 1, 1994
Syndrome of continuous muscle fiber activity and plasmacytoma with IgM paraproteinemiaU Zifko, M Drlicek, E Machacek, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
A broader horizon of Alzheimer pathogenesis: ALZAS--an early serum biomarker?E Kienzl, K Jellinger, B Janetzky, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
General properties of 14C-L-Valine-binding to human brain tissueP Riederer, E Kienzl, K Jellinger, et al.
Acta Neurochirurgica|January 1, 1979
Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomasK Jellinger, P Kothbauer, D Volc, et al.
Der Nervenarzt|January 5, 2001
[Dementia with Lewy bodies]G Ransmayr, G K Wenning, K Seppi, et al.
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1979
[Metabolic factors in the pathogenesis of consciousness disorders and coma]P Riederer, G Kleinberger, W D Rausch, et al.
Zeitschrift Fur Gastroenterologie|December 1, 1978
[Biochemistry of hepatic encephalopathy]P Riederer, K Jellinger, W D Rausch, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
Tranylcypromine isomers in Parkinson's disease. Effect of low doses on monoamine oxidase inhibition and blood pressure responseP Riederer, G P Reynolds, K Jellinger, et al.
Pageof 37

Showing results (241-250 of 364) with videos related to

Sort By:
Pageof 37
Neuropathology and Applied Neurobiology|October 16, 2010
Review: sporadic cerebral amyloid angiopathyJ Attems, K Jellinger, D R Thal, et al.
FEBS Letters|April 24, 1990
A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick diseaseR Weiler, H Lassmann, P Fischer, et al.
Neurology|March 1, 1994
Syndrome of continuous muscle fiber activity and plasmacytoma with IgM paraproteinemiaU Zifko, M Drlicek, E Machacek, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
A broader horizon of Alzheimer pathogenesis: ALZAS--an early serum biomarker?E Kienzl, K Jellinger, B Janetzky, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
General properties of 14C-L-Valine-binding to human brain tissueP Riederer, E Kienzl, K Jellinger, et al.
Acta Neurochirurgica|January 1, 1979
Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomasK Jellinger, P Kothbauer, D Volc, et al.
Der Nervenarzt|January 5, 2001
[Dementia with Lewy bodies]G Ransmayr, G K Wenning, K Seppi, et al.
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1979
[Metabolic factors in the pathogenesis of consciousness disorders and coma]P Riederer, G Kleinberger, W D Rausch, et al.
Zeitschrift Fur Gastroenterologie|December 1, 1978
[Biochemistry of hepatic encephalopathy]P Riederer, K Jellinger, W D Rausch, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
Tranylcypromine isomers in Parkinson's disease. Effect of low doses on monoamine oxidase inhibition and blood pressure responseP Riederer, G P Reynolds, K Jellinger, et al.
Pageof 37